Taniguchi K, Nonami T, Nakao A, Harada A, Kurokawa T, Sugiyama S, Fujitsuka N, Shimomura Y, Hutson S M, Harris R A, Takagi H
Department of Surgery II, Nagoya University School of Medicine, Japan.
Hepatology. 1996 Dec;24(6):1395-8. doi: 10.1002/hep.510240614.
The activities of key enzymes in the valine catabolic pathway--branched-chain aminotransferase, branched-chain alpha-keto acid dehydrogenase complex, methacrylyl (MC)-coenzyme A (CoA) hydratase (crotonase), and 3-hydroxyisobutyryl-CoA (HIB-CoA) hydrolase--were measured in normal and cirrhotic human livers. Unlike rat liver, which does not contain branched-chain aminotransferase, the aminotransferase activity in the normal liver was measurable and is increased somewhat in cirrhosis of the human liver. The total activity of branched-chain alpha-keto acid dehydrogenase complex in the normal human liver was approximately 1% of that in rat liver, and 20% to 30% of the complex was in the active form in both normal and cirrhotic livers. Only the actual activity of the enzyme was significantly decreased by cirrhosis. These results suggest that human liver is less active than rat liver in the catabolism of branched-chain amino and alpha-keto acids. Activities of MC-CoA hydratase and HIB-CoA hydrolase in human liver were very high compared with that of branched-chain alpha-keto acid dehydrogenase complex, suggesting an important role for these enzymes in catabolism of a potentially toxic compound, MC-CoA, formed as an intermediate in the catabolism of valine and isobutyrate. Cirrhosis resulted in a significant decrease in HIB-CoA hydrolase activity but had no effect on the citrate synthase activity, suggesting that the decrease in HIB-CoA hydrolase activity does not reflect a general decrease in mitochondria but that it may contribute to cellular damage that culminates in liver failure.
在正常和肝硬化的人肝脏中,测定了缬氨酸分解代谢途径中关键酶的活性,这些酶包括支链氨基转移酶、支链α-酮酸脱氢酶复合体、甲基丙烯酰辅酶A水合酶(巴豆酸酶)和3-羟基异丁酰辅酶A水解酶。与大鼠肝脏不同,大鼠肝脏不含支链氨基转移酶,而正常肝脏中的氨基转移酶活性是可测量的,并且在人类肝硬化肝脏中有所增加。正常人类肝脏中支链α-酮酸脱氢酶复合体的总活性约为大鼠肝脏的1%,在正常和肝硬化肝脏中,该复合体的20%至30%处于活性形式。只有该酶的实际活性因肝硬化而显著降低。这些结果表明,在支链氨基酸和α-酮酸的分解代谢中,人类肝脏的活性低于大鼠肝脏。与支链α-酮酸脱氢酶复合体相比,人类肝脏中甲基丙烯酰辅酶A水合酶和3-羟基异丁酰辅酶A水解酶的活性非常高,这表明这些酶在分解代谢一种潜在有毒化合物甲基丙烯酰辅酶A中起重要作用,甲基丙烯酰辅酶A是缬氨酸和异丁酸分解代谢过程中形成的中间体。肝硬化导致3-羟基异丁酰辅酶A水解酶活性显著降低,但对柠檬酸合酶活性没有影响,这表明3-羟基异丁酰辅酶A水解酶活性的降低并不反映线粒体的普遍减少,但可能导致最终导致肝衰竭的细胞损伤。